NasdaqGS - Delayed Quote USD

Cross Country Healthcare, Inc. (CCRN)

17.57 -0.20 (-1.13%)
At close: April 24 at 4:00 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 8888
Avg. Estimate 0.170.180.911.19
Low Estimate 0.150.130.770.88
High Estimate 0.20.231.051.55
Year Ago EPS 0.840.692.330.91

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 8888
Avg. Estimate 374.09M362.51M1.48B1.53B
Low Estimate 370.3M350M1.39B1.34B
High Estimate 375.23M374.28M1.53B1.63B
Year Ago Sales 595M531.68M2.02B1.48B
Sales Growth (year/est) -37.10%-31.80%-26.70%3.70%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 0.750.610.410.27
EPS Actual 0.840.690.390.29
Difference 0.090.08-0.020.02
Surprise % 12.00%13.10%-4.90%7.40%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.170.180.911.19
7 Days Ago 0.170.190.931.22
30 Days Ago 0.170.190.931.22
60 Days Ago 0.210.231.111.33
90 Days Ago 0.290.351.431.69

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --111

Growth Estimates

CURRENCY IN USD CCRNIndustrySectorS&P 500
Current Qtr. -79.80%----1.50%
Next Qtr. -73.90%----11.40%
Current Year -60.90%----5.20%
Next Year 30.80%----13.40%
Next 5 Years (per annum) 10.00%----11.09%
Past 5 Years (per annum) 118.30%------

Research Analysis

Analyst Price Targets

16.00 Low
19.17 Average
17.57 Current
24.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Barrington Research: Outperform to Outperform 2/27/2024
Maintains Truist Securities: Hold to Hold 2/22/2024
Maintains Benchmark: Buy to Buy 2/22/2024
Initiated JMP Securities: Market Perform 12/6/2023
Initiated UBS: Neutral 11/30/2023
Maintains Barrington Research: Outperform to Outperform 11/29/2023

Related Tickers